Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > MF HOLDINGS
MF Holdings      
Gland Pharma Ltd.
BSE Code 543245
ISIN Demat INE068V01023
Book Value 556.82
NSE Code GLAND
Dividend Yield % 1.13
Market Cap 291569.36
P/E 26.44
EPS 66.94
Face Value 1  
Scheme NameMarket Val (In Crs.)AUM(In Crs.)Hold Percentage
HDFC Mid-Cap Opportunities Fund(G) 997.07 77682.9 1.28
Mirae Asset Large & Midcap Fund-Reg(G) 662.20 40670.04 1.63
SBI Large & Midcap Fund-Reg(IDCW) 520.81 29234.37 1.78
Nippon India Growth Fund(G) 502.85 35208.97 1.43
ICICI Pru India Opp Fund(G) 466.17 24792.55 1.88
Mirae Asset ELSS Tax Saver Fund-Reg(G) 422.96 26417.64 1.60
Mirae Asset Large Cap Fund-Reg(G) 385.33 42179.27 0.91
Mirae Asset Midcap Fund-Reg(G) 379.62 17787.87 2.13
Nippon India Small Cap Fund(G) 314.86 62259.55 0.51
HDFC Large and Mid Cap Fund-Reg(G) 282.81 24508.23 1.15
Nippon India Pharma Fund(G) 269.38 8768.67 3.07
HDFC Manufacturing Fund-Reg(G) 264.00 13630.95 1.94
Nippon India Multi Cap Fund(G) 254.38 39621.82 0.64
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G) 230.75 4987.49 4.63
Aditya Birla SL Frontline Equity Fund(G) 219.31 31389.18 0.70
Mirae Asset Focused Fund-Reg(G) 205.95 8653.39 2.38
Nippon India ELSS Tax Saver Fund(G) 197.55 16711 1.18
ICICI Pru Value Discovery Fund(G) 187.54 51197.82 0.37
ICICI Pru Equity & Debt Fund(G) 171.57 41395.98 0.41
UTI Flexi Cap Fund-Reg(IDCW) 150.14 27706.23 0.54
Page 1 of 6
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.